The Effect Of Proton Pump Inhibitors On The Development Of Hepatic Encephalopathy
DOI:
https://doi.org/10.62480/tjms.2026.vol53.pp9-12Keywords:
Liver cirrhosis, hepatic encephalopathy, proton pump inhibitorsAbstract
The most common complications associated with cirrhosis are neurological and neuropsychiatric disorders, referred to as hepatic encephalopathy (HE). Proton pump inhibitors (PPI) cannot be without risk, as recent studies have shown a clear link between PPI and conditions such as encephalopathy. IPP work by suppressing acid, which can disrupt intestinal microbiomes. Patients with cirrhosis are at risk of developing hepatic encephalopathy (HE), mainly due to the ammonia produced by the typical intestinal flora, and may subsequently be at risk of changes in this condition if the microbiome changes in any way.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.











